Cargando…
Commentary: Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy?
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406637/ https://www.ncbi.nlm.nih.gov/pubmed/34476215 http://dx.doi.org/10.3389/fonc.2021.712358 |
_version_ | 1783746536263385088 |
---|---|
author | Fargeas, Christine A. Lorico, Aurelio Corbeil, Denis |
author_facet | Fargeas, Christine A. Lorico, Aurelio Corbeil, Denis |
author_sort | Fargeas, Christine A. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8406637 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84066372021-09-01 Commentary: Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy? Fargeas, Christine A. Lorico, Aurelio Corbeil, Denis Front Oncol Oncology Frontiers Media S.A. 2021-08-12 /pmc/articles/PMC8406637/ /pubmed/34476215 http://dx.doi.org/10.3389/fonc.2021.712358 Text en Copyright © 2021 Fargeas, Lorico and Corbeil https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Fargeas, Christine A. Lorico, Aurelio Corbeil, Denis Commentary: Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy? |
title | Commentary: Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy? |
title_full | Commentary: Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy? |
title_fullStr | Commentary: Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy? |
title_full_unstemmed | Commentary: Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy? |
title_short | Commentary: Could We Address the Interplay Between CD133, Wnt/β-Catenin, and TERT Signaling Pathways as a Potential Target for Glioblastoma Therapy? |
title_sort | commentary: could we address the interplay between cd133, wnt/β-catenin, and tert signaling pathways as a potential target for glioblastoma therapy? |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406637/ https://www.ncbi.nlm.nih.gov/pubmed/34476215 http://dx.doi.org/10.3389/fonc.2021.712358 |
work_keys_str_mv | AT fargeaschristinea commentarycouldweaddresstheinterplaybetweencd133wntbcateninandtertsignalingpathwaysasapotentialtargetforglioblastomatherapy AT loricoaurelio commentarycouldweaddresstheinterplaybetweencd133wntbcateninandtertsignalingpathwaysasapotentialtargetforglioblastomatherapy AT corbeildenis commentarycouldweaddresstheinterplaybetweencd133wntbcateninandtertsignalingpathwaysasapotentialtargetforglioblastomatherapy |